NEW YORK (GenomeWeb) – Oxford Biodynamics announced today that it has signed a collaboration agreement with Holos Life Sciences to develop non-invasive epigenetic biomarkers linked to sports-related concussions.

Under the terms of the agreement, Holos will supply the participants' blood samples, while Oxford will provide its EpiSwitch platform and methodology for the development, evaluation, and validation of epigenetic biomarkers. The test's biomarker readouts will be based on minimally invasive blood testing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.